CEL-SCI
CVM
CEL-SCI (CVM) news
Recent news
Cel-Sci Corporation Q2 EPS USD -0.47
AInvest Wire · Aug 17, 2026Cel-Sci Corp - patient enrollment to begin in U.S., Europe, Asia, and South America
AInvest Wire · Jul 13, 2026Cel-Sci Corp - to launch Phase 3 confirmatory study for Multikine in head and neck cancer
AInvest Wire · Jul 13, 2026Cel-Sci and Saudi AmaroX hold strategic agreement signing ceremony at Bio 2026, advancing U.S.–Saudi cooperation in cancer care
AInvest Wire · Jun 24, 2026Cel-Sci announces closing of offering
CEL-SCI Corporation (NYSE American: CVM) has announced the completion of a public offering involving 6,000,000 shares of its common stock, with each share priced at $1.20, generating approximately $7.2 million in gross proceeds before fees and expenses. The offering, facilitated by ThinkEquity as…
AInvest Wire · Jun 16, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.